Chronobiome
An academic research initiative at the University of Pennsylvania focused on the human chronobiome.
ChronobiomeChronobiome is an academic research initiative led by Dr. Carsten Skarke at the University of Pennsylvania. It focuses on the "chronobiome," a term coined in 2017 to describe the unique pattern of physiological traits and biological rhythms—including circadian clocks and molecular oscillations—that regulate a person's physiology, metabolism, and behavior over a 24-hour period.
The initiative's research spans personalized medicine, aging, and postoperative care, aiming to align treatments and lifestyle interventions with individual biological rhythms to improve efficacy and reduce side effects. The team is currently developing paradigms within the University of Pennsylvania Hospital Systems to quantify sleep-wake rhythms using digital technologies to enhance patient outcomes.
By integrating multiomics, clinical data, and remote sensing, the research seeks to understand how the disruption of chronobiological rhythms relates to metabolic disorders, cardiovascular disease, mental health, and cancer. This work is relevant to precision medicine and has attracted interest from pharmaceutical entities seeking non-invasive tools to detect metabolic changes.
Ideas that could help Chronobiome
- E. limosum Probiotic for Kidney Health
A specialized probiotic containing Eubacterium limosum designed to maintain gut-derived UDCA levels to protect against kidney injury.
Why it helps: Companies specializing in precision microbiome engineering can develop a stable delivery system for E. limosum.
- E. limosum Renal-Protective Probiotic
A specialized probiotic supplement containing Eubacterium limosum designed to boost endogenous UDCA production as a long-term preventative measure for high-risk renal patients.
Why it helps: Companies focusing on metabolite-driven health could use this as a wedge for 'metabolite-tuning' services.